IP Verse

Weickmann & Weickmann Partmbb opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Weickmann & Weickmann Partmbb

Patent Number:
EP3911354
Title:
Aav-Mediated Gene Therapy Restoring The Otoferlin Gene
Applicant:
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
Opposition Date:
Apr 18, 2024
Patent Number:
EP3451898
Title:
Overlay Imaging For Registration Of A Patient Eye For Laser Surgery
Applicant:
ALCON INC.
Opposition Date:
Mar 21, 2024
Patent Number:
EP3368047
Title:
Synthetic Composition And Method For Modulating Emotion And Mood Disorders
Applicant:
GLYCOM A/S
Opposition Date:
Jan 25, 2024
Patent Number:
EP3021700
Title:
Electronic Smoking Article With Haptic Feedback
Applicant:
RAI STRATEGIC HOLDINGS, INC.
Opposition Date:
Dec 8, 2023
Patent Number:
EP4066819
Title:
Small Liposomes For Delivery Of Immunogen-Encoding Rna
Applicant:
GLAXOSMITHKLINE BIOLOGICALS SA
Opposition Date:
Nov 30, 2023
Patent Number:
EP4043040
Title:
Small Liposomes For Delivery Of Immunogen-Encoding Rna
Applicant:
GLAXOSMITHKLINE BIOLOGICALS SA
Opposition Date:
Oct 11, 2023
Patent Number:
EP4008357
Title:
Small Liposomes For Delivery Of Immunogen-Encoding Rna
Applicant:
GLAXOSMITHKLINE BIOLOGICALS SA
Opposition Date:
Sep 27, 2023
Patent Number:
EP4066857
Title:
Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna
Applicant:
GLAXOSMITHKLINE BIOLOGICALS SA
Opposition Date:
Sep 20, 2023
Patent Number:
EP4066856
Title:
Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna
Applicant:
GLAXOSMITHKLINE BIOLOGICALS SA
Opposition Date:
Sep 7, 2023
Patent Number:
EP3452050
Title:
Composition Comprising Hmos For The Treatment Of Non-Infectious Diarrhoea
Applicant:
GLYCOM A/S
Opposition Date:
Aug 23, 2023

Competitors of Weickmann & Weickmann Partmbb

GLAXOSMITHKLINE BIOLOGICALS SA

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS S.A.

Want to track Weickmann & Weickmann Partmbb?

Feel free to send us a message here and we will get back to you